| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other expense | -1,331 | -1,435 | -1,126 | -2,617 |
| Loss before income taxes | -1,134 | -2,254 | -50,794 | -4,491 |
| Income tax expense (benefit) | 97 | 28 | -454 | 311 |
| Net loss | -1,231 | -2,282 | -50,340 | -4,802 |
| Basic loss per share (in dollars per share) | -0.03 | -0.05 | -1.14 | -0.11 |
| Diluted loss per share (in dollars per share) | -0.03 | -0.05 | -1.14 | -0.11 |
| Us-gaap_weightedaveragenumberofdilutedsharesoutstanding | 44,556,000 | 44,303,000 | 44,096,000 | 43,614,000 |
| Weighted average shares outstanding - basic (in shares) | 44,556,000 | 44,303,000 | 44,096,000 | 43,614,000 |
HARVARD BIOSCIENCE INC (HBIO)
HARVARD BIOSCIENCE INC (HBIO)